Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.
- DOI
- 10.1038/s41591-023-02399-0
- Published
- 2023 Jun
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-023-02399-0,
title = {Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.},
author = {Yap TA and Fontana E and Lee EK and Spigel DR and Højgaard M and Lheureux S and Mettu NB and Carneiro BA and Carter L and Plummer R and Cote GM and Meric-Bernstam F and O'Connell J and Schonhoft JD and Wainszelbaum M and Fretland AJ and Manley P and Xu Y and Ulanet D and Rimkunas V and Zinda M and Koehler M and Silverman IM and Reis-Filho JS and Rosen E},
year = {2023},
journal = {Nature medicine},
doi = {10.1038/s41591-023-02399-0},
url = {https://doi.org/10.1038/s41591-023-02399-0}
}RIS
TY - JOUR TI - Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results. AU - Yap TA AU - Fontana E AU - Lee EK AU - Spigel DR AU - Højgaard M AU - Lheureux S AU - Mettu NB AU - Carneiro BA AU - Carter L AU - Plummer R AU - Cote GM AU - Meric-Bernstam F AU - O'Connell J AU - Schonhoft JD AU - Wainszelbaum M AU - Fretland AJ AU - Manley P AU - Xu Y AU - Ulanet D AU - Rimkunas V AU - Zinda M AU - Koehler M AU - Silverman IM AU - Reis-Filho JS AU - Rosen E PY - 2023 JO - Nature medicine DO - 10.1038/s41591-023-02399-0 UR - https://doi.org/10.1038/s41591-023-02399-0 ER -
APA
TA, Y., E, F., EK, L., DR, S., M, H., S, L., NB, M., BA, C., L, C., R, P., GM, C., F, M., J, O., JD, S., M, W., AJ, F., P, M., Y, X., D, U., V, R., M, Z., M, K., IM, S., JS, R., & E, R. (2023). Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results.. Nature medicine. https://doi.org/10.1038/s41591-023-02399-0
Source records
- pubmed · retrieved 2026-09-27T15:30:19.410Z